Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Refractory (Phase 1/Phase 2)
Bone Neoplasms (Phase 1)
Breast Neoplasms (Phase 2)
Carcinoma (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 1)
Carcinoma, Renal Cell (Phase 2)
Colonic Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 1)
Drugs, Investigational (Phase 1/Phase 2)
Eye Neoplasms (Phase 1)
Fallopian Tube Neoplasms (Phase 1)
Glioblastoma (Phase 2)
Glioma (Phase 1)
Gliosarcoma (Phase 2)
Hamartoma (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 1/Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 1/Phase 2)
Lung Neoplasms (Phase 1/Phase 2)
Lymphoma, Follicular (Phase 1)
Melanoma (Phase 3)
Myelodysplastic Syndromes (Phase 1/Phase 2)
Myeloproliferative Disorders (Phase 1)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neoplasms by Site (Phase 2)
Osteoarthritis, Knee (Phase 1)
Ovarian Neoplasms (Phase 1)
Pneumonia (Early Phase 1)
Primary Myelofibrosis (Phase 1)
Pulmonary Disease, Chronic Obstructive (Early Phase 1)
Rectal Neoplasms (Phase 1)
Sarcoma (Phase 1)
Skin Neoplasms (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 1/Phase 2)
Thrombocythemia, Essential (Phase 1)
Triple Negative Breast Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue